Emmanuel Blin is the founder and CEO of Tech Care for All (TC4A), a social impact company whose goal is to accelerate digital health in Africa and Asia as key enabler to improve health outcomes in underserved communities. Having grown up in sub-Saharan Africa, Emmanuel has a deep commitment to making our world a healthier and more equitable place. His vision is to bridge digital health innovation happening in the U.S., Asia, Europe and Africa and with the numerous unmet healthcare needs of Africa and Asia. Emmanuel created Tech Care for All (TC4A) in 2017 after 20 y
Pam Bolton serves as Tech Care for All’s head of global health and social impact lead. She brings to TC4A her decades of work in sub-Saharan Africa, her lifelong dedication to the health and rights of women and children and her expertise in forging multi-sector partnerships for social good. From 2014-7 Pam was VP for Global Health and Innovation with Concern Worldwide U.S., an international development and humanitarian organization. There she led the establishment of Concern’s Centre for Innovation and Health and directed Innovations for Maternal, New
Marc Delavarenne serves as Tech Care for All’s Head of Operations. He brings to TC4A his sales & marketing experience from the pharmaceutical industry, his ability to manage cross-functional projects and his 4 years’ experience on customer centricity across international organizations. Marc spent the last 4 years as Head of Customer Experience for Bristol-Myers Squibb France, then for the Global organization leading the design and deployment of a new customer-centric approach that has won several awards from customer associations. From 2008 to 2014, M
Dr Sachin Malhotra, PhD is an innovator & entrepreneur who has founded & successfully brought to market companies in India & the USA. With 15+ years of rich experience in the healthcare industry, Sachin brings to TC4A a unique techno-commercial skill set to implement our digital healthcare strategy and improve lives of millions of people. Sachin has held positions at Ranbaxy Research Labs (India), Oklahoma Medical Research Foundation (OMRF, USA), Altheus Therapeutics Inc. (USA), the Immune Tolerance Network (ITN, USA), BIDMC at Harvard Medical School (US